Meet the official partner organisations for ICPR 2022
ICPR is organised by the OPEN Foundation, a non-profit organisation from the Netherlands. We’re supported not only by a small army of volunteers – but also by our sponsors. Some of them have been with us for years, and we’d like to both acknowledge their strong contribution to the OPEN Foundation as well as introduce them to you so you have a better understanding of our network. We’d like to thank all of our sponsors and partners for their help and support in making this conference happen.
ICPR will happen thanks to these partner organisations:
Multidisciplinary Association for Psychedelic Studies (MAPS)
Founded in 1986, MAPS is a non-profit research and educational organisation investigating psychedelic substances for improving human life. They are currently running a large Phase III trial for MDMA for those struggling with post-traumatic stress disorder (PTSD) with pioneer researchers in the field, which may lead to the US Food and Drugs Administration (FDA) approval for treating PTSD.
As one of the biggest communities for people interested in psychedelic experiences, Psychedelics Today offers a wide range of educational resources for both clinicians and interested members of the public. They actively hold both online and in-person events for their members, as well as providing online courses from topics including both challenging and transformational aspects of psychedelics. In addition to these, they offer a 12-month professional certificate training on psychedelic therapy and integration called “Vital” starting from April 2023, aimed to qualify clinicians to be ready for a psychedelic renaissance in therapy possibly in near future.
A clinical-stage natural psychedelic drug development company working for clinical trials authorised by the US Food and Drugs Administration (FDA) to treat a wide range of mental health issues. Filament Health partnered with the University of California, San Francisco (UCSF) in their Translational Psychedelic Research Program (TrPR) in 2021 for two clinical trials.
Founded in 2019, Cybin is a biopharmaceutical company that is primarily known for engineering next-generation psychedelic molecules, such as a psilocybin analog called CYB003 – a potential breakthrough treatment for treatment-resistant depression. Currently running several clinical trials with different psychedelic analogs, Cybin aims to transform the treatment of various psychiatric and neurological conditions.
A new company aiming to manufacture and internationally provide high quality psychedelic compounds at scale while donating up to 10% of all of their profits to nonprofit entities that offer access to therapy for low-income and minority groups and research centres advancing understanding of psychedelics.
California Institute of Integral Studies (CIIS)
At the beautiful location of San Francisco, California, CIIS is a private research university at the forefront of cutting-edge ideas, integrating diverse disciplines, redefining boundaries with an innovative approach since 1968. CIIS is well-known for their certificate programs in Psychedelic Research and Human Sexuality, but also for their Counselling Psychology program, which was ranked 4th among other California universities.
With growing interest in the intersection of music and psychedelic-assisted therapy that allows for a more transformational outcome, Wavepaths is one of the first companies to offer person-centred music to over 300 practitioners from both large and private clinics in over 30 countries including – but not limited to – the US, Canada, Europe, Asia, and Africa.
Stemming from a family owned business committed to caring for living beings, Dr. Bronner’s offers high quality products including organic soap and personal care products that improve overall health while being socially and environmentally responsible for a better world.
Founded in 1998 by Amanda Feilding, also known as the queen of the psychedelic renaissance, Beckley Foundation has been pioneering global drug policy reform and scientific research into psychoactive substances and the human mind.
RiverStyx Foundation is a dynamic charitable organisation dedicated to embracing darkness while lighting up the world with light, hope for future, by providing funding to under-respresented projects to promote collective healing, compassion, and ecological balance.
Usona Institute is a nonprofit medical research organisation committed to supporting and conducting both pre-clinical and clinical research to improve knowledge of the therapeutic effects of psychedelic substances, primarily psilocybin, inspired by the study from John Hopkins University for cancer patients.
An online platform dedicated to advance knowledge of pharmacovigilance via comprehensive resources based on scientific research including chemical and psychopharmacological information on psychedelic substances.
Leafy Tunnel is an early-stage venture capital firm investing in alternative medicine to address mental health and pain disorders.